Related references
Note: Only part of the references are listed.Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis
Nigel P. S. Crawford et al.
PLOS GENETICS (2007)
The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation
Shwu-Yuan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer
Anna V. Ivshina et al.
CANCER RESEARCH (2006)
Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial
Jan Bogaerts et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Breast cancer expression profiling: the impact of microarray testing on clinical decision making
Olga Modlich et al.
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer
NPS Crawford et al.
BREAST CANCER RESEARCH (2006)
Metastasis predictive signature profiles pre-exist in normal tissues
HY Yang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1
YG Park et al.
NATURE GENETICS (2005)
The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription
MK Jang et al.
MOLECULAR CELL (2005)
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients
HY Dai et al.
CANCER RESEARCH (2005)
Modifiers of mammary tumor progression and metastasis on mouse Chromosomes 7, 9, and 17
M Lancaster et al.
MAMMALIAN GENOME (2005)
Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization
A Farina et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis
HY Yang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
The curability of breast cancer and the treatment of advanced disease
V Guarneri et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
A molecular signature of metastasis in primary solid tumors
S Ramaswamy et al.
NATURE GENETICS (2003)
Goals and objectives in the management of metastatic breast cancer
CT Chung et al.
ONCOLOGIST (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A mammalian bromodomain protein, Brd4, interacts with replication factor C and inhibits progression to S phase
T Maruyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4
D Houzelstein et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Gene-expression profiles in hereditary breast cancer.
I Hedenfalk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A bromodomain protein, MCAP, associates with mitotic chromosomes and effects, G2-to-M transition
A Dey et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Systematic variation in gene expression patterns in human cancer cell lines
DT Ross et al.
NATURE GENETICS (2000)